Butterfly Network

Butterfly Network

BFLY
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $1.7B

Market Cap: $1.1BFounded: 2011Employees: 251-500HQ: Burlington, United States

Overview

Butterfly Network's mission is to make medical imaging universally accessible by fundamentally re-engineering ultrasound technology. The company has achieved this through its proprietary Ultrasound-on-Chip™, which replaces traditional piezoelectric crystals with a semiconductor-based system, enabling a single, affordable handheld probe for whole-body imaging. Its strategy centers on building a comprehensive 'connected medicine' ecosystem that combines the physical device with AI-driven software, workflow tools, and education to drive adoption across clinical specialties and healthcare settings. With a public valuation of approximately $1.05B, Butterfly is a leader in the point-of-care ultrasound (POCUS) market transformation.

AnesthesiologyCardiologyCritical CareEmergency MedicineGlobal HealthMusculoskeletalPrimary CareUrologyWomen's Health

Technology Platform

Proprietary Ultrasound-on-Chip™ technology using semiconductor-based Capacitive Micromachined Ultrasonic Transducers (CMUTs) to enable a single, handheld probe for whole-body imaging, replacing traditional piezoelectric crystal systems.

Funding History

8
Total raised:$1.7B
IPO$292.5M
IPO$250M
Series C$250M
Series C$250M

Opportunities

Butterfly is positioned to capitalize on the rapid growth of the point-of-care ultrasound market, driven by healthcare decentralization and cost containment.
Its platform model creates recurring revenue from software and services, while its Butterfly Embedded™ initiative opens a new B2B licensing channel for its core chip technology.

Risk Factors

Key risks include execution challenges in a competitive market against well-funded incumbents, the need to achieve sustainable revenue growth and a path to profitability, and potential technological competition that could erode its first-mover advantage.

Competitive Landscape

Butterfly competes with established giants like GE, Philips, and Fujifilm in portable ultrasound, as well as newer handheld rivals. Its primary differentiators are its proprietary Ultrasound-on-Chip™ technology enabling whole-body imaging in one probe, and its integrated ecosystem of hardware, AI software, and education.

Company Timeline

2011Founded

Founded in Burlington, United States

2018Series C

Series C: $250.0M

2018Series C

Series C: $250.0M

2021IPO

IPO — $292.5M